PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, is thrilled and proud to announce that it has been named to the 37th Annual Inc. 5000 list, recognizing the fastest-growing private companies in America. PANTHERx® is being recognized...

PANTHERx® Specialty Pharmacy (PANTHERx®), THE Rare Disease Specialty Pharmacy®, announced that it has been selected by Otsuka America Pharmaceutical, Inc. (Otsuka) to distribute JYNARQUE™ (tolvaptan), the only FDA-approved therapy for patients diagnosed...

PANTHERx® Specialty Pharmacy, THE Rare Disease Specialty Pharmacy®, has been named the winner of the Specialty Pharmacy Patient Choice Award™ for the non-PBM/payer category. This is the second consecutive year this award has been bestowed on PANTHERx...

PANTHERx Specialty Pharmacy®, THE Rare Disease Specialty Pharmacy®, announced today that it has received the Verified Internet Pharmacy Practice Sites (VIPPS) accreditation from the National Association of Boards of Pharmacy (NABP), an association that...

Press Release originally published on PRNewswire PITTSBURGH, PA – The Center for Pharmacy Practice Accreditation (CPPA), a partnership of pharmacy-based organizations, announced today that it has awarded specialty pharmacy practice accreditation to PANTHERx...

Re-posted from PR Newswire PANTHERx® Specialty Pharmacy has been recognized as the winner of the Specialty Pharmacy Patient Choice Awards™ for the non-PBM/payer category presented during the 2017 Asembia Specialty Pharmacy Summit in Las Vegas, Nevada. ...